134 related articles for article (PubMed ID: 21158873)
1. Human subjects research with prisoners: putting the ethical question in context.
Obasogie OK; Reiter KA
Bioethics; 2011 Jan; 25(1):55-6. PubMed ID: 21158873
[No Abstract] [Full Text] [Related]
2. Regulatory orphans: juvenile prisoners as transvulnerable research subjects.
Reed JG
IRB; 1999; 21(2):9-14. PubMed ID: 11657875
[No Abstract] [Full Text] [Related]
3. The paradoxical case of payment as benefit to research subjects.
Macklin R
IRB; 1989; 11(6):1-3. PubMed ID: 11650284
[No Abstract] [Full Text] [Related]
4. Making research a requirement of treatment: why we should sometimes let doctors pressure patients to participate in research.
Orentlicher D
Hastings Cent Rep; 2005; 35(5):20-8. PubMed ID: 16295261
[TBL] [Abstract][Full Text] [Related]
5. How not to rethink research ethics.
Beauchamp TL
Am J Bioeth; 2005; 5(1):31-3; author reply W15-8. PubMed ID: 16036653
[No Abstract] [Full Text] [Related]
6. [A welcome guide for evaluating medical research involving human subjects].
Borst-Eilers E
Ned Tijdschr Geneeskd; 2003 May; 147(19):898-900. PubMed ID: 12768802
[TBL] [Abstract][Full Text] [Related]
7. Protecting vulnerable research subjects: practical realities of institutional review board review and approval.
Wichman A
J Health Care Law Policy; 1998; 1(1):88-104. PubMed ID: 15573431
[No Abstract] [Full Text] [Related]
8. Equipoise and the ethics of clinical research revisited.
Miller FG
Am J Bioeth; 2006; 6(4):59-61; discussion W42-5. PubMed ID: 16885110
[No Abstract] [Full Text] [Related]
9. An IRB member's perspective on access to innovative therapy.
Moore DL
Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854
[No Abstract] [Full Text] [Related]
10. Ethics. Human health research ethics.
Silbergeld E; Lerman S; Hushka L
Science; 2004 Aug; 305(5686):949. PubMed ID: 15310879
[No Abstract] [Full Text] [Related]
11. When do the federal regulations allow placebo-controlled trials in children?
Miller FG; Wendler D; Wilfond B
J Pediatr; 2003 Feb; 142(2):102-7. PubMed ID: 12584527
[No Abstract] [Full Text] [Related]
12. What's in a name?
Benham B
Am J Bioeth; 2008 Apr; 8(4):47-9. PubMed ID: 18576257
[No Abstract] [Full Text] [Related]
13. Regulating research on the terminally ill: a proposal for heightened safeguards.
Addicott DC
J Contemp Health Law Policy; 1999; 15(2):479-524. PubMed ID: 10394764
[No Abstract] [Full Text] [Related]
14. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects.
Maloney DM
Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342
[No Abstract] [Full Text] [Related]
15. The changing clinical trials scene: the role of the IRB.
Mitchell SC; Steingrub J
IRB; 1988; 10(4):1-5. PubMed ID: 11650078
[No Abstract] [Full Text] [Related]
16. A new rule for vulnerable research subjects has some special provisions.
Hum Res Rep; 1994 Jun; 9(6):1-2. PubMed ID: 11654129
[No Abstract] [Full Text] [Related]
17. Subjects or objects? Prisoners and human experimentation.
Lerner BH
N Engl J Med; 2007 May; 356(18):1806-7. PubMed ID: 17476006
[No Abstract] [Full Text] [Related]
18. Some questionable premises about research ethics.
Macklin R
Am J Bioeth; 2005; 5(1):29-31; author reply W15-8. PubMed ID: 16036652
[No Abstract] [Full Text] [Related]
19. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
20. Protectionism and the new research imperative in pediatric AIDS.
Ackerman TF
IRB; 1990; 12(5):1-5. PubMed ID: 11654001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
